Surgical management of ovarian cancer

Thomas C. Randall, Stephen C. Rubin

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations

Abstract

Ovarian cancer affects over 25,000 women each year in the United States. The performance of appropriate surgery for ovarian cancer is critical in directing further therapies and improving survival. Systematic surgical staging must be performed in patients who appear to have early stage ovarian cancer because a significant proportion of these women have occult metastases. A marked improvement in survival has been demonstrated in patients with bulky disease if all masses larger than 2 cm can be surgically removed. Despite the dramatic effect of surgery on the subsequent course of the disease, recent studies show that only a minority of women with ovarian cancer receive appropriate initial surgery. We review the evidence and rationale for systematic surgical treatment of ovarian cancer.

Original languageEnglish
Pages (from-to)173-180
Number of pages8
JournalSeminars in Surgical Oncology
Volume17
Issue number3
DOIs
StatePublished - Oct 1999

Keywords

  • Adenocarcinoma
  • Adnexal diseases
  • Biopsy
  • CA- 125 antigen
  • Combined antineoplastic agents
  • Laparoscopy
  • Lymph nodes
  • Mass screening
  • Neoplasm metastasis
  • Neoplasm staging
  • Ovarian neoplasms/etiology/diagnosis/surgery/pathology/drug therapy
  • Quality of life
  • Survival rate

Fingerprint

Dive into the research topics of 'Surgical management of ovarian cancer'. Together they form a unique fingerprint.

Cite this